Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland

Table 2 Health state utility values

Source	HS1	HS2	HS3	HS4	HS5
Acaster Lloyd (EQ-5D-5L) [5]	0.71	0.62	0.52	0.35	0.15
Acaster Lloyd (HUI3; used in scenario analysis) [5]	0.52	0.36	0.22	0.14	-0.04

Key: HS1, moderate visual impairment; HS2, severe visual impairment; HS3, profound visual impairment; HS4, counting fingers; HS5, vision ranging from being able to see hand motion to having no light perception at all.
EQ-5D-5L five-level version of the EQ-5D-5L instrument, HS health state, HUI-3 Health Utilities Index Mark 3.

ISSN: 1472-6963